Fibre eases constipation and nudges gut-brain chemistry too

Fibre is the standard first-line advice for functional constipation, yet how it works has never been fully pinned down. The traditional explanation is mechanical: fibre bulks and softens stool so it moves more easily. But fibre is also food for gut microbes, which produce short-chain fatty acids and influence serotonin signalling, both part of the two-way communication between the gut and the brain. This analysis asked two questions at once: how well does fibre actually relieve constipation across randomised trials, and do gut-brain biomarkers move alongside the symptoms?

The researchers searched four databases, PubMed, Embase, Web of Science and Cochrane CENTRAL, from inception to January 2026 for randomised controlled trials of fibre supplementation in patients with Rome-diagnosed functional constipation. Fourteen trials with 1,284 participants qualified. Primary outcomes were spontaneous bowel movements, complete spontaneous bowel movements and stool consistency. Secondary outcomes tracked the biological story: short-chain fatty acids, serotonin and inflammatory markers. Results were pooled using random-effects models to produce overall estimates of effect.

Fibre delivered on the clinical outcomes: 1.42 extra spontaneous bowel movements per week, 0.96 extra complete ones, and a meaningful improvement in stool consistency. The biomarkers moved too, with increases in total short-chain fatty acids and serotonin and a reduction in inflammatory markers. Soluble, fermentable fibres at more than 10 g per day taken for at least 4 weeks showed greater efficacy than other approaches. The certainty of the evidence was rated moderate to high, though the authors stress the biomarker changes are exploratory and their clinical significance is not yet established.

The symptom findings confirm what guidelines already say: fibre works for functional constipation. The novelty is the biomarker picture, which is consistent with fibre doing more than bulking stool, possibly acting through microbial metabolites and serotonin signalling along the gut-brain axis. The authors are explicit that this does not prove fibre restores gut-brain function; the marker shifts could be bystanders rather than mechanisms. Whether the fibre type, the dose threshold and the duration pattern hold up in head-to-head trials are the obvious next questions.

If constipation is a recurring issue, this is strong pooled evidence that fibre supplementation genuinely helps, and a hint that the details matter: soluble, fermentable types, at more than 10 g a day and continued for at least 4 weeks, performed best here. It is also a reason to be patient, since the better results came with sustained use rather than quick fixes. The gut-brain findings are intriguing but unproven, so they are a reason for curiosity rather than a reason to expect mood effects from a fibre supplement.